Awarded
Vemurafenib, Dornasa Alfa, Vismodegib, Cobimetinib, Alectinib, Emicizumab, Polatuzumab, Pertuzumab/Trastuzumab, Risdiplam, Faricimab, Entrectinib y Satralizu
Track this recordFree account — get alerted when a contract here runs out.
- Buyer
- Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad
- Winners
- ROCHE PHARMA, S.A.
- Contract value
- €37,442,622
- Bids received
- 1
- Published
- 11 Jul 2025
- Awarded
- 10 Jul 2025
- Contract start
- 10 Jul 2025
- Contract end
- 11 Jul 2026estimated
- Region
- Valencia/València